← Leaderboards
Li Zhang
Mellon Pitts Corporation (Mpc Corp)
$9,468,854
Attributed
$13,627,246
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,627,246 · 11
By mechanism
R01$6,895,614 · 5
RF1$5,921,402 · 2
R21$411,501 · 1
R56$375,417 · 1
P20$23,312 · 1
P41$0 · 1
Top collaborators
- Quan Jiang6 shared
- Ye Xiong2 shared
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusCerebrumAgedElderlyBrainMediatingPlayBlood VesselsBlood - Brain Barrier AnatomyResponseFunctional DisorderGenesThrombosisMolecularCerebrovascularDiabetes MellitusImpairmentBrain Endothelial CellTherapeutic EffectMicrornasExosomeImpaired CognitionExhibitsMiddle Age
Grant awards (28)
Efflux Route Responses of Cerebral Waste Clearance During Progression of Alzheimerâs Disease$3,062,355
RF1 · FY2025 · AG
Imaging cerebral waste clearance responses during exosome treatment of diabetes$551,682
R01 · FY2025 · DK
AcSDKP as a novel treatment for traumatic brain injury$388,051
R01 · FY2025 · NS
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats$379,316
R01 · FY2025 · AG · contact PI
Imaging cerebral waste clearance responses during exosome treatment of diabetes$612,980
R01 · FY2024 · DK
AcSDKP as a novel treatment for traumatic brain injury$431,168
R01 · FY2024 · NS
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats$387,057
R01 · FY2024 · AG · contact PI
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats$358,623
R01 · FY2023 · AG · contact PI
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats$358,623
R01 · FY2022 · AG · contact PI
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats$358,623
R01 · FY2021 · AG · contact PI
Combination treatment with Vepoloxamer and tPA for acute stroke$329,219
R01 · FY2021 · NS · contact PI
Combination treatment with Vepoloxamer and tPA for acute stroke$329,219
R01 · FY2020 · NS · contact PI
Combination treatment with Vepoloxamer and tPA for acute stroke$329,219
R01 · FY2019 · NS · contact PI
Combination treatment with Vepoloxamer and tPA for acute stroke$329,219
R01 · FY2018 · NS · contact PI
Glymphatic and cognitive impairment of aging and diabetes$2,859,047
RF1 · FY2017 · AG
Cerebral endothelial derived-exosomes improve cognitive function in aged diabetic rat$375,417
R56 · FY2017 · AG · contact PI
Combination treatment with Vepoloxamer and tPA for acute stroke$328,125
R01 · FY2017 · NS · contact PI
Impairment of the glymphatic system in the aged diabetic brain$224,626
R21 · FY2017 · AG
Impairment of the glymphatic system in the aged diabetic brain$186,875
R21 · FY2016 · AG
Treatment of stroke with a clinically approved proteasome inhibitor$285,469
R01 · FY2012 · NS · contact PI
Treatment of stroke with a clinically approved proteasome inhibitor$285,469
R01 · FY2011 · NS · contact PI
Treatment of stroke with a clinically approved proteasome inhibitor$282,614
R01 · FY2010 · NS · contact PI
NONLINEAR OPTICAL ABSORPTION OF DNA-FUNCTIONALIZED CARBON NANOTUBES$23,312
P20 · FY2010 · RR · contact PI
Treatment of stroke with a clinically approved proteasome inhibitor$285,469
R01 · FY2009 · NS · contact PI
Treatment of stroke with a clinically approved proteasome inhibitor$285,469
R01 · FY2008 · NS · contact PI
PART II: ANALYSIS OF PROTEIN TYROSINE SULFATION$0
P41 · FY2002 · RR
PART II: ANALYSIS OF PROTEIN TYROSINE SULFATION$0
P41 · FY2002 · RR
PART II: ANALYSIS OF PROTEIN TYROSINE SULFATION$0
P41 · FY2001 · RR